Tumoral and stromal hMENA isoforms impact tertiary lymphoid structure localization in lung cancer and predict immune checkpoint blockade response in patients with cancer-Reference-Cited by-同舟云学术

Tumoral and stromal hMENA isoforms impact tertiary lymphoid structure localization in lung cancer and predict immune checkpoint blockade response in patients with cancer

Published:2024-03 Issue: Volume:101 Page:105003
ISSN:2352-3964
Container-title:eBioMedicine
language:en
Short-container-title:eBioMedicine

Author:

Di Modugno Francesca^ORCID,Di Carlo Anna,Spada Sheila^ORCID,Palermo Belinda,D'Ambrosio Lorenzo^ORCID,D'Andrea Daniel,Morello Gaia,Belmonte Beatrice,Sperduti Isabella,Balzano Vittoria,Gallo Enzo,Melchionna Roberta,Panetta Mariangela,Campo Giulia,De Nicola Francesca,Goeman Frauke,Antoniani Barbara,Carpano Silvia,Frigè Gianmaria^ORCID,Warren Sarah,Gallina Filippo^ORCID,Lambrechts Diether,Xiong Jieyi,Vincent Benjamin G.,Wheeler Nathan,Bortone Dante S.,Cappuzzo Federico,Facciolo Francesco,Tripodo Claudio,Visca Paolo,Nisticò Paola^ORCID

Funder

Cancer Research Institute

Ministero della Salute

Fondazione Italiana per la Ricerca sul Cancro Airc

ACC

Publisher

Elsevier BV

Reference54 articles.

1. Preoperative and postoperative systemic therapy for operable non-small-cell lung cancer;Chaft;J Clin Oncol,2022

2. Understanding the tumor immune microenvironment (TIME) for effective therapy;Binnewies;Nat Med,2018

3. Updated analysis of KEYNOTE-024: pembrolizumab versus platinum-based chemotherapy for advanced non-small-cell lung cancer with PD-L1 tumor proportion score of 50% or greater;Reck;J Clin Oncol,2019

4. Immunotherapy for the first-line treatment of patients with metastatic non-small cell lung cancer;Martinez;Clin Cancer Res,2019

5. Approaches to treat immune hot, altered and cold tumours with combination immunotherapies;Galon;Nat Rev Drug Discov,2019

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Oncolytic herpes simplex virus propagates tertiary lymphoid structure formation via CXCL10/CXCR3 to boost antitumor immunity;Cell Proliferation;2024-09

2. Macrophages and tertiary lymphoid structures as indicators of prognosis and therapeutic response in cancer patients;Biochimica et Biophysica Acta (BBA) - Reviews on Cancer;2024-09

3. The role of BUD31 in clear cell renal cell carcinoma: prognostic significance, alternative splicing, and tumor immune environment;Clinical and Experimental Medicine;2024-08-13